Another Black Eye For Cooper

Weak sales. Towering expenses. Questionable deals. Allegations of executive greed. Irate shareholders. This is the combustible mix that for years has swirled around Cooper Cos., a New York health care outfit specializing in contact lenses--and, apparently, misadventure.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.